PureTech Health plc
Business
PureTech Health plc is a biopharmaceutical company developing therapeutic product candidates across multiple modalities. The company advances a diversified pipeline of internally developed programs and products through subsidiary entities, focusing on rare and serious diseases. PureTech leverages validated biology with proprietary inventive steps to de-risk drug development. The company pursues regulatory approvals in the United States, European Union, and other jurisdictions to commercialize approved products.
Summary from 20-F filed 2026-04-29
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $-110.08M |
| Total assets | $534.71M |
| Total liabilities | $229.03M |
| Stockholders' equity | — |
| Operating cash flow | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is PureTech Health plc's CIK number?
PureTech Health plc's SEC CIK number is 0001782999 (1782999). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find PureTech Health plc's SEC filings?
All of PureTech Health plc's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.